GoodRx Holdings Inc. (NASDAQ:GDRX) went up by 3.64% from its latest closing price compared to the recent 1-year high of $59.67. The company’s stock price has collected -1.84% of loss in the last five trading sessions. Press Release reported 8 hours ago that GoodRx Announces Date for Third Quarter 2021 Earnings Release and Conference Call
Is It Worth Investing in GoodRx Holdings Inc. (NASDAQ :GDRX) Right Now?
Opinions of the stock are interesting as 7 analysts out of 15 who provided ratings for GoodRx Holdings Inc. declared the stock was a “buy,” while 2 rated the stock as “overweight,” 5 rated it as “hold,” and 1 as “sell.”
The average price from analysts is $43.79, which is $0.46 above the current price. GDRX currently public float of 69.32M and currently shorts hold a 22.32% ratio of that float. Today, the average trading volume of GDRX was 1.70M shares.
GDRX’s Market Performance
GDRX stocks went down by -1.84% for the week, with a monthly drop of -5.60% and a quarterly performance of 40.65%, while its annual performance rate touched -19.22%. The volatility ratio for the week stands at 5.85% while the volatility levels for the past 30 days are set at 5.49% for GoodRx Holdings Inc.. The simple moving average for the period of the last 20 days is -2.70% for GDRX stocks with a simple moving average of 6.69% for the last 200 days.
Analysts’ Opinion of GDRX
Many brokerage firms have already submitted their reports for GDRX stocks, with Barclays repeating the rating for GDRX by listing it as a “Overweight.” The predicted price for GDRX in the upcoming period, according to Barclays is $45 based on the research report published on August 31st of the current year 2021.
Raymond James, on the other hand, stated in their research note that they expect to see GDRX reach a price target of $45. The rating they have provided for GDRX stocks is “Outperform” according to the report published on August 13th, 2021.
Robert W. Baird gave a rating of “Neutral” to GDRX, setting the target price at $37 in the report published on May 28th of the current year.
GDRX Trading at 7.63% from the 50-Day Moving Average
After a stumble in the market that brought GDRX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -29.43% of loss for the given period.
Volatility was left at 5.49%, however, over the last 30 days, the volatility rate increased by 5.85%, as shares sank -4.92% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +33.09% upper at present.
During the last 5 trading sessions, GDRX fell by -1.84%, which changed the moving average for the period of 200-days by -3.37% in comparison to the 20-day moving average, which settled at $43.17. In addition, GoodRx Holdings Inc. saw 4.39% in overturn over a single year, with a tendency to cut further gains.
Reports are indicating that there were more than several insider trading activities at GDRX starting from Azad Babak, who sale 7,500 shares at the price of $40.91 back on Oct 11. After this action, Azad Babak now owns 0 shares of GoodRx Holdings Inc., valued at $306,838 using the latest closing price.
NAGJI BANSI, the President, Healthcare of GoodRx Holdings Inc., sale 3,600 shares at $45.05 during a trade that took place back on Oct 07, which means that NAGJI BANSI is holding 29,166 shares at $162,187 based on the most recent closing price.
Stock Fundamentals for GDRX
Current profitability levels for the company are sitting at:
- -48.55 for the present operating margin
- +91.28 for the gross margin
The net margin for GoodRx Holdings Inc. stands at -53.32. The total capital return value is set at -30.10, while invested capital returns managed to touch -33.46. Equity return is now at value -41.50, with -20.60 for asset returns.
Based on GoodRx Holdings Inc. (GDRX), the company’s capital structure generated 99.10 points at debt to equity in total, while total debt to capital is 49.77. Total debt to assets is 47.16, with long-term debt to equity ratio resting at 97.47. Finally, the long-term debt to capital ratio is 48.96.
When we switch over and look at the enterprise to sales, we see a ratio of 28.21, with the company’s debt to enterprise value settled at 0.05. The receivables turnover for the company is 7.57 and the total asset turnover is 0.58. The liquidity ratio also appears to be rather interesting for investors as it stands at 18.24.